Skip to content

Robbert J. Verkes

6 papers in the library · 457 citations · publishing 2008-2022

Papers

Sort Most recent Most cited

Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.

Addiction (Abingdon, England) 2022 Thomas Knuijver, Arnt Schellekens, Maarten Belgers et al. 49 citations

Ibogaine is an indole alkaloid used in rituals of the African Bwiti tribe. It is also used in non-medical settings to treat addiction. However, ibogaine has been linked to several deaths, mainly due to cardiac events called torsades des pointes preceded by QTc prolongation as well as other safety concerns. This study aimed to evaluate the cardiac, cerebellar and psychomimetic safety of ibogaine...

Cannabis and tolerance: acute drug impairment as a function of cannabis use history

Scientific Reports May 26, 2016 Johannes G. Ramaekers, J. H. van Wel, Desirée Spronk et al. 81 citations

Cannabis use history as predictor of neurocognitive response to cannabis intoxication remains subject to scientific and policy debates. The present study assessed the influence of cannabis on neurocognition in cannabis users whose cannabis use history ranged from infrequent to daily use. Drug users (N = 122) received acute doses of cannabis (300 μg/kg THC), cocaine HCl (300 mg) and placebo....

Treatment of heroin dependence with ibogaine

European Psychiatry March 1, 2016 Arnt Schellekens, Toon Van Oosteren, Thomas Knuijver et al. 1 citation

Background The use of the hallucinogen ibogaine as an anti-addiction agent has been described in several case reports, dating back to the eighties. The anti-addiction properties of ibogaine have been confirmed in a large body of animal work. Ibogaine has been shown to be effective in reducing withdrawal severity and substance use for a variety of substances, including cocaine and opiates....

Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users

British Journal of Pharmacology October 11, 2013 Janelle H. P. van Wel, Kim P. C. Kuypers, Eef L. Theunissen et al. 38 citations

BACKGROUND AND PURPOSE: Cannabis is the most popular drug used in the European Union, closely followed by cocaine. Whereas cannabis impairs neurocognitive function in occasional cannabis users, such impairments appear less prominent in heavy users, possibly as a result of tolerance. The present study was designed to assess whether the impairing effects of Δ(9) -tetrahydrocannabinol (THC) in...

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

Social Neuroscience June 25, 2009 Glenn Dumont, Fred C.g.j. Sweep, R. van der Steen et al. 238 citations

MDMA (3,4-methylenedioxymethamphetamine or "ecstasy") is a recreationally used drug with remarkable and characteristic prosocial effects. In spite of abundant attention in the scientific literature, the mechanism of its prosocial effects has not been elucidated in humans. Recently, research in animals has suggested that the neuropeptide oxytocin may induce these effects. In a double blind,...

Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers

Psychopharmacology February 28, 2008 Glenn Dumont, E. Wezenberg, M. M. G. J. Valkenberg et al. 50 citations

Co-administration of MDMA and ethanol did not exacerbate the effects of either drug alone. Although the impairment of performance by all drug conditions was relatively moderate, all induced significant impairment of cognitive function.